Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Express Scripts
Harvard Business School
Johnson and Johnson
Merck

Last Updated: October 16, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ACLIDINIUM BROMIDE

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Aclidinium Bromide

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00358436 Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD) Completed AstraZeneca Phase 3 2006-08-01 To evaluate the efficacy and safety of LAS 34273 compared to placebo in patients with moderate to severe COPD during one year of treatment.
NCT00363896 A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD) Completed AstraZeneca Phase 3 2006-07-01 To evaluate the efficacy and safety of LAS 34273 compared to placebo in patients with moderate to severe COPD during one year of treatment.
NCT00435760 Clinical Trial to Assess Rate of Onset of Bronchodilator Action in Severe Stable Chronic Obstructive Pulmonary Disease (COPD) Patients Completed AstraZeneca Phase 3 2007-02-01 This trial evaluates the rate of onset of bronchodilator action of aclidinium bromide compared to placebo and tiotropium in patients with severe COPD after a single dose treatment.
NCT00500318 A Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Completed AstraZeneca Phase 3 2007-07-01 This study evaluated the effect of inhaled aclidinium bromide on exercise endurance and in reducing resting and dynamic lung hyperinflation in patients with moderate to severe COPD. It was 9 weeks in duration, consisting of; a 2-week run-in period, 6 weeks of double-blind treatment, and a 1-week follow-up phone call. All patients meeting the eligibility criteria were randomized to one of two treatment groups: aclidinium bromide or placebo.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Aclidinium Bromide

Condition Name

Condition Name for Aclidinium Bromide
Intervention Trials
Chronic Obstructive Pulmonary Disease (COPD) 13
Chronic Obstructive Pulmonary Disease 13
Pulmonary Disease, Chronic Obstructive 7
COPD 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Aclidinium Bromide
Intervention Trials
Pulmonary Disease, Chronic Obstructive 36
Lung Diseases 35
Lung Diseases, Obstructive 31
Chronic Disease 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Aclidinium Bromide

Trials by Country

Trials by Country for Aclidinium Bromide
Location Trials
United States 400
Canada 49
Germany 12
Australia 11
Hungary 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Aclidinium Bromide
Location Trials
North Carolina 15
South Carolina 15
Florida 15
Oregon 14
Arizona 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Aclidinium Bromide

Clinical Trial Phase

Clinical Trial Phase for Aclidinium Bromide
Clinical Trial Phase Trials
Phase 4 9
Phase 3 20
Phase 2 9
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Aclidinium Bromide
Clinical Trial Phase Trials
Completed 30
Not yet recruiting 4
Recruiting 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Aclidinium Bromide

Sponsor Name

Sponsor Name for Aclidinium Bromide
Sponsor Trials
AstraZeneca 32
Parexel 2
Menarini Group 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Aclidinium Bromide
Sponsor Trials
Industry 42
Other 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Colorcon
Baxter
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.